Published in
BMJ Publishing Group, Journal of Clinical Pathology, 6(55), p. 461-466
DOI: 10.1136/jcp.55.6.461
Links
- ORCID
- BMJ Publishing Group
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin
Journal article published in 2002 by
T. Megha,
Francesco Ferrari,
A. Benvenuto,
Cristiana Bellan,
Lalinga Av,
Av V. Lalinga,
Stefano Lazzi 
,
S. Bartolommei,
Gabriele Cevenini,
Lorenzo Leoncini,
Piero Tosi
,
S. Bartolommei,
Gabriele Cevenini,
Lorenzo Leoncini,
Piero Tosi
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Aim: Several studies have investigated the expression of the cytokeratins (CKs), vimentin, the epithelial growth factor receptor (EGFR), the oestrogen receptor (ER), and the progesterone receptor (PgR), in breast cancer, but no study has directly compared p53 mutations with these phenotypic and differentiation markers in the same case. The present study was designed to provide some of this information.